Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.J. Seo
Cost-Utility Analysis of Dabrafenib/Trametinib Combination (D+t) for Brafv600 Mutation-Positive Metastatic Melanoma (Mm) From the United Kingdom (Uk) National Health Service (Nhs) Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Improved Overall Survival in Melanoma With Combined Dabrafenib and Trametinib
New England Journal of Medicine
Medicine
Trametinib: A MEK Inhibitor for Management of Metastatic Melanoma
OncoTargets and Therapy
Oncology
Pharmacology
Gender, Mentoring and Social Capital in the National Health Service (NHS) in Scotland, UK
Gender, Careers and Inequalities in Medicine and Medical Education: International Perspectives
A Cost-Utility Analysis of Lighterlife Total as a Treatment for Obesity in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ian Holliday: The National Health Service(NHS) Transformed
Revija Za Socijalnu Politiku
Sociology
International Relations
Political Science
Cost of the National Health Service
The Lancet
Medicine
Peritoneal Dialysis and In-Centre Haemodialysis: A Cost-Utility Analysis From a UK Payer Perspective
Applied Health Economics and Health Policy
Medicine
Health Policy
Economics
Econometrics
